Sanofi Announces Ambitious $1 Billion Investment to Enhance Manufacturing Capabilities in China

In a significant move aimed at boosting its production capabilities, French pharmaceutical giant Sanofi has unveiled plans for a substantial $1 billion investment in China. This initiative is designed to enhance the company's manufacturing footprint within one of the world's most dynamic markets, further solidifying its operational base in Asia.

Continue reading